Target intelligence / Profile preview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 (MT-ND2)

Target
MT-ND2
Molecular classification
Enzyme, Mitochondrial respiratory chain complex I subunit
01

Overview

Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 (MT-ND2) is a protein-coding gene that forms a core component of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase). Located in the inner mitochondrial membrane, MT-ND2 is essential for electron transfer from NADH to ubiquinone, a key step in the mitochondrial electron transport chain, supporting ATP synthesis via oxidative phosphorylation. Pathogenic mutations in MT-ND2 are causally linked to several mitochondrial disorders, especially Leber hereditary optic neuropathy and complex I deficiency, and are implicated as genetic modifiers in a variety of other diseases, including some cancers and neurodegenerative conditions[1][2][3][4][7].

Other names
NADH-ubiquinone oxidoreductase chain 2MTND2NADH2ND2NAD2NADH dehydrogenase subunit 2Complex I ND2 subunitMitochondrial NADH dehydrogenase IINADH-II
02

Mechanism of action

Not directly targeted by pharmaceuticals; mechanistic disruption or mutation affects electron transport, leading to mitochondrial dysfunction

03

Biological functions

Electron transport in the mitochondrial respiratory chainNADH oxidationATP production via oxidative phosphorylationMitochondrial respiratory chain complex I assembly
04

Disease associations

Leber hereditary optic neuropathyMitochondrial complex I deficiencyMyocardial infarctionNeurodegenerative diseases (multiple)Urinary bladder cancerModifier in type 1 diabetes (model organism evidence)
05

Safety considerations

Mitochondrial toxicity risk if function is inadvertently affectedPotential for off-target mitochondrial dysfunction in therapies modulating electron transportGenetic heterogeneity complicates therapeutic intervention
06

Biomarkers

Mutations serve as genetic biomarkers for mitochondrial disorders, notably Leber hereditary optic neuropathy and mitochondrial complex I deficiency

Beyond the preview

Go deeper on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 (MT-ND2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 (MT-ND2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call